Madurai News

Delveinsight Business Research LLP

Diverticulitis is a digestive condition that affects the large intestine (bowel). Diverticulosis is a condition that occurs when small pouches, or sacs, form and push outward through weak spots in the wall of the colon. Diverticulitis occurs when one has diverticulosis and one or a few of the pouches in the wall of the colon become inflamed.

Experts are not sure what causes diverticulitis. Researchers are studying several factors that may play a role in causing these conditions such as a low/high fiber diet, certain genes which are leading to Diverticulitis. Certain medicines—including nonsteroidal anti-inflammatory drugs (NSAIDs), lack of exercise, obesity, smoking, etc. are also linked to factors responsible for causing Diverticulitis. Diverticulitis can come on suddenly and cause other problems, such as Abscess, Perforation, Peritonitis, Fistula, Intestinal obstruction, etc.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/diverticulitis-market

The Diverticulitis Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Diverticulitis market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Diverticulitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Diverticulitis Market Key Facts

• According to the “National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center”: About 70,000 people are hospitalized for diverticular bleeding each year. Experts used to think that 10 to 25 % of people with diverticulosis would develop diverticulitis. However, newer research suggests that the percentage who develop diverticulitis may be much lower—less than 5 percent.

• As per the study conducted by Imaeda, H., & Hibi, T. et al. (2018), Diverticulitis may be acute or chronic and uncomplicated or complicated by a diverticular abscess, fistula, bowel obstruction, or free perforation. Approximately 4–15% of patients with diverticulosis develop diverticulitis.

• Among people ages 50 and older, women are more likely than men to develop diverticulitis. However, among people younger than age 50, men are more likely to develop diverticulitis

• According to the study titled “Epidemiology, Pathophysiology, and Treatment of Diverticulitis” conducted by Lisa L. Strate et al. (2019): Diverticulitis is a prevalent gastrointestinal disorder that is associated with significant morbidity and health care costs. Approximately 20% of patients with incident diverticulitis have at least 1 recurrence.

Key Benefits of Diverticulitis Market Report

• Diverticulitis market report provides an in-depth analysis of Diverticulitis Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

• The report will help in developing business strategies by understanding the Diverticulitis Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

• The market report covers the Diverticulitis current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

• The report provides a detailed assessment of the Diverticulitis market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Diverticulitis Market

Diverticulitis market size is expected to increase during the forecast period owing to the rise in the Diverticulitis population, increased funding by governmental bodies, and vigorous R&D activities.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Diverticulitis market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

 The report gives a thorough detail of the Diverticulitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Diverticulitis Epidemiology

The epidemiology section covers insights about the historical and current Diverticulitis patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Diverticulitis Epidemiology Segmentation

• Total Prevalent Cases of Diverticulitis 

• Gender-specific Prevalent Cases of Diverticulitis

• Diagnosed and Treatable Cases of Diverticulitis 

• Age-specific Prevalent Cases of Diverticulitis

Diverticulitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diverticulitis market or expected to get launched in the market during the study period. The analysis covers Diverticulitis market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Diverticulitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Diverticulitis market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for Diverticulitis emerging therapies.

The mainstays of treatment for patients with uncomplicated Diverticulitis include antibiotics, dietary modification, and pain control. Surgical resection has been the cornerstone for the treatment of complicated diverticulitis and recurrence. However, these interventions are based largely on dogma and expert opinion rather than data. Traditional surgical recommendations were comfortingly definitive but ultimately have not been supported by evidence.

The dynamics of the Diverticulitis market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, and the incremental healthcare spending across the world. At present some of the key pharmaceutical companies are working toward the development of potential therapies in order to fulfill the unmet medical needs of the currently used therapeutics.

Diverticulitis Companies 

• Emmaus Medical

• Cosmo Pharmaceuticals 

And others

Diverticulitis Therapies covered in the report include:

• Endari

• Aemcolo

And many others.

As per the DelveInsight, the Diverticulitis market size shall grow during the forecast period owing to the launch of upcoming therapies and increased patient pool.

Table of Content

1. Key Insights

2. Executive Summary 

3. Diverticulitis Competitive Intelligence Analysis

4. Diverticulitis Market Overview at a Glance

5. Diverticulitis Disease Background and Overview

6. Diverticulitis Patient Journey

7. Diverticulitis Epidemiology and Patient Population

8. Diverticulitis Treatment Algorithm, Current Treatment, and Medical Practices

9. Diverticulitis Unmet Needs

10. Key Endpoints of Diverticulitis Treatment

11. Diverticulitis Marketed Products

12. Diverticulitis Emerging Therapies

13. Diverticulitis Seven Major Market Analysis

14. Attribute Analysis

15. Diverticulitis Market Outlook (7 major markets)

16. Diverticulitis Access and Reimbursement Overview

17. KOL Views on the Diverticulitis Market.

18. Diverticulitis Market Drivers

19. Diverticulitis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/diverticulitis-market

Latest Reports By DelveInsight
Diverticulitis Pipeline Insights
Diverticulitis Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Diverticulitis market.

Frontotemporal Dementia Market
DelveInsight’s “Frontotemporal Dementia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Frontotemporal Dementia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/